Ketamine

Recent articles

Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read

Explore more from The Transmitter

Speech bubbles progress from light- to dark- colored.

Amid funding uncertainty, neuroscientists report a mix of cynicism, persistence

Two years into one of the most tumultuous tenures in U.S. federal funding, researchers outline how they are coping with ongoing changes and reflect on the impact these changes are having on the system more broadly.

By Emily Singer
28 August 2026 | 5 min read
Stages of neurodegeneration: Neurofibrillary tangles at different stages of neurodegeneration are labeled with phosphorylated tau antibodies (green and blue).

Reimagining Mexico’s brain bank

Since Alzheimer’s disease researcher José Luna-Muñoz assumed leadership of the facility—Latin America’s oldest—in 2011, he has been acquiring additional tissue types and is working to expand donor recruitment to rural areas.

By Alejandra Manjarrez
28 August 2026 | 7 min read

Revealing how crabs make their escape

Houdini-like Neohelice granulata offers a rare opportunity to record intracellularly from awake, behaving animals.

By Natalia Mesa
28 August 2026 | 0 min watch